Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 75

1.

Dimerization of SLX4 contributes to functioning of the SLX4-nuclease complex.

Yin J, Wan B, Sarkar J, Horvath K, Wu J, Chen Y, Cheng G, Wan K, Chin P, Lei M, Liu Y.

Nucleic Acids Res. 2016 Jun 2;44(10):4871-80. doi: 10.1093/nar/gkw354. Epub 2016 Apr 29.

2.

Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation.

Liu Q, Underwood TS, Kung J, Wang M, Lu HM, Paganetti H, Held KD, Hong TS, Efstathiou JA, Willers H.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):78-85. doi: 10.1016/j.ijrobp.2016.01.046. Epub 2016 Feb 1.

3.

Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance.

Kim Y.

Mol Cells. 2014 Aug;37(8):569-74. doi: 10.14348/molcells.2014.0118. Epub 2014 Jun 18. Review.

4.

Assessment of SLX4 Mutations in Hereditary Breast Cancers.

Shah S, Kim Y, Ostrovnaya I, Murali R, Schrader KA, Lach FP, Sarrel K, Rau-Murthy R, Hansen N, Zhang L, Kirchhoff T, Stadler Z, Robson M, Vijai J, Offit K, Smogorzewska A.

PLoS One. 2013 Jun 26;8(6):e66961. doi: 10.1371/journal.pone.0066961. Print 2013.

5.

Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.

de Garibay GR, Díaz A, Gaviña B, Romero A, Garre P, Vega A, Blanco A, Tosar A, Díez O, Pérez-Segura P, Díaz-Rubio E, Caldés T, de la Hoya M.

Eur J Hum Genet. 2013 Aug;21(8):883-6. doi: 10.1038/ejhg.2012.268. Epub 2012 Dec 5.

6.

Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.

Bakker JL, van Mil SE, Crossan G, Sabbaghian N, De Leeneer K, Poppe B, Adank M, Gille H, Verheul H, Meijers-Heijboer H, de Winter JP, Claes K, Tischkowitz M, Waisfisz Q.

Hum Mutat. 2013 Jan;34(1):70-3. doi: 10.1002/humu.22206. Epub 2012 Oct 11.

PMID:
22911665
7.

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.

Fernández-Rodríguez J, Quiles F, Blanco I, Teulé A, Feliubadaló L, Valle JD, Salinas M, Izquierdo A, Darder E, Schindler D, Capellá G, Brunet J, Lázaro C, Pujana MA.

BMC Cancer. 2012 Mar 8;12:84. doi: 10.1186/1471-2407-12-84.

8.

Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.

Catucci I, Colombo M, Verderio P, Bernard L, Ficarazzi F, Mariette F, Barile M, Peissel B, Cattaneo E, Manoukian S, Radice P, Peterlongo P.

PLoS One. 2012;7(2):e31038. doi: 10.1371/journal.pone.0031038. Epub 2012 Feb 23.

9.

Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer.

Landwehr R, Bogdanova NV, Antonenkova N, Meyer A, Bremer M, Park-Simon TW, Hillemanns P, Karstens JH, Schindler D, Dörk T.

Breast Cancer Res Treat. 2011 Dec;130(3):1021-8. doi: 10.1007/s10549-011-1681-1. Epub 2011 Jul 31.

PMID:
21805310
10.

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.

Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP.

Nat Genet. 2011 Feb;43(2):138-41. doi: 10.1038/ng.751. Epub 2011 Jan 16.

PMID:
21240277
11.

BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres.

Sobinoff AP, Allen JA, Neumann AA, Yang SF, Walsh ME, Henson JD, Reddel RR, Pickett HA.

EMBO J. 2017 Oct 2;36(19):2907-2919. doi: 10.15252/embj.201796889. Epub 2017 Sep 6.

PMID:
28877996
12.

Paternal or Maternal Uniparental Disomy of Chromosome 16 Resulting in Homozygosity of a Mutant Allele Causes Fanconi Anemia.

Donovan FX, Kimble DC, Kim Y, Lach FP, Harper U, Kamat A, Jones M, Sanborn EM, Tryon R, Wagner JE, MacMillan ML, Ostrander EA, Auerbach AD, Smogorzewska A, Chandrasekharappa SC.

Hum Mutat. 2016 May;37(5):465-8. doi: 10.1002/humu.22962. Epub 2016 Feb 23.

13.

Physical interaction between SLX4 (FANCP) and XPF (FANCQ) proteins and biological consequences of interaction-defective missense mutations.

Hashimoto K, Wada K, Matsumoto K, Moriya M.

DNA Repair (Amst). 2015 Nov;35:48-54. doi: 10.1016/j.dnarep.2015.09.022. Epub 2015 Sep 30.

14.

The nuclease hSNM1B/Apollo is linked to the Fanconi anemia pathway via its interaction with FANCP/SLX4.

Salewsky B, Schmiester M, Schindler D, Digweed M, Demuth I.

Hum Mol Genet. 2012 Nov 15;21(22):4948-56. doi: 10.1093/hmg/dds338. Epub 2012 Aug 19.

PMID:
22907656
15.

Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia.

Lachaud C, Castor D, Hain K, Muñoz I, Wilson J, MacArtney TJ, Schindler D, Rouse J.

J Cell Sci. 2014 Jul 1;127(Pt 13):2811-7. doi: 10.1242/jcs.146167. Epub 2014 May 2.

16.

Holliday junction-resolving enzymes-structures and mechanisms.

Lilley DMJ.

FEBS Lett. 2017 Apr;591(8):1073-1082. doi: 10.1002/1873-3468.12529. Epub 2017 Jan 1. Review.

17.

Activation of the DNA Damage Response Is a Conserved Function of HIV-1 and HIV-2 Vpr That Is Independent of SLX4 Recruitment.

Fregoso OI, Emerman M.

MBio. 2016 Sep 13;7(5). pii: e01433-16. doi: 10.1128/mBio.01433-16.

18.

Identification and characterization of MUS81 point mutations that abolish interaction with the SLX4 scaffold protein.

Nair N, Castor D, Macartney T, Rouse J.

DNA Repair (Amst). 2014 Dec;24:131-137. doi: 10.1016/j.dnarep.2014.08.004. Epub 2014 Sep 16.

19.

Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions.

Garner E, Kim Y, Lach FP, Kottemann MC, Smogorzewska A.

Cell Rep. 2013 Oct 17;5(1):207-15. doi: 10.1016/j.celrep.2013.08.041. Epub 2013 Sep 27.

20.

Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A, Trujillo JP, Minguillón J, Ramírez MJ, Pujol R, Casado JA, Baños R, Rio P, Knies K, Zúñiga S, Benítez J, Bueren JA, Jaspers NG, Schärer OD, de Winter JP, Schindler D, Surrallés J.

Am J Hum Genet. 2013 May 2;92(5):800-6. doi: 10.1016/j.ajhg.2013.04.002. Epub 2013 Apr 25.

Supplemental Content

Support Center